Company

IMPORTANT NOTICE
As of December 19th, 2011 the "UroTec GmbH" changed its name to "UroTiss GmbH".

UroTiss GmbH is a pharmaceutical company, founded in Germany in 2005. UroTiss provides products with highest safety and quality, in accordance to current Good Manufacturing Practices (GMP).

company company

The company's patented technologies are positioned in the growing field of tissue-engineering while using the patients' own cells for the treatment of his urologic disease.

Current indications for company's first product include treatment of urethral stricture and hypospadia.

Further intended indications are treatment of ureteral strictures, ureteral anomalies, and sever urinary bladder diseases.

All marketing and sales-related activities, from logistics up to physician trainings, manufacturing and quality assurance, are focused on achieving excellent and high quality products. We keep working hard on the development of further products to treat complex diseases in the field of urogenital system together with an interdisciplinary team composed by renowned scientists and physicians.

Leading specialized urologic centers in Europe use our first product MukoCell® in the treatment of urethral stricture.

The executive board of UroTiss is represented by Gouya Ram-Liebig, MD (research & development and production) and by Sören Liebig (regulatory affairs and finances).

 
EVENTS

18.01.2012
Solemn opening of the laboratories at the "Tatzberg"

23.-26.01.2012
Arab Health - booth ZD 51
Arab Health

24.-28.02.2012
EAU Congress

EAU

 

 

 

 

 

Patienten-Beratung